Evidence map›Paper›PMID 40766325›Full record

ArticleFrontiers in immunology2025

High-dimensional single-cell phenotyping unveils persistent differences in immune cell profiles between severe and moderate seasonal influenza.

Johanna Bodin, Gro Tunheim, Anja B Kristoffersen, Tove K Herstad, Eleonora Vianello, Mariëlle C Haks, Suzanne van Veen, Torgun Wæhre, Anne-Marte B Kran, Sarah L Lartey and 7 more

Erratum issuedAbstract read
In one paragraph

Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Multivariate Host-Pathogen Interactions Driving Heterogeneous Viral Shedding and CD8medRxiv : the preprint server for health sciences · 2025
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors.

Johanna BodinSection of Immunology, Department of Method Development and Analytics, Norwegian Institute of Public Health, Oslo, Norway.
Gro TunheimSection of Immunology, Department of Method Development and Analytics, Norwegian Institute of Public Health, Oslo, Norway.
Anja B KristoffersenSection of Immunology, Department of Method Development and Analytics, Norwegian Institute of Public Health, Oslo, Norway.
Tove K HerstadSection of Immunology, Department of Method Development and Analytics, Norwegian Institute of Public Health, Oslo, Norway.
Eleonora VianelloDepartment of Infectious Diseases, Leiden University Medical Center, Leiden, Netherlands.
Mariëlle C HaksDepartment of Infectious Diseases, Leiden University Medical Center, Leiden, Netherlands.
Suzanne van VeenDepartment of Infectious Diseases, Leiden University Medical Center, Leiden, Netherlands.
Torgun WæhreDepartment of Infectious Diseases, Oslo University Hospital, Oslo, Norway.
Anne-Marte B KranDivision of Infection Control, Department of Infectious Disease Registries, Norwegian Institute of Public Health, Oslo, Norway.
Sarah L LarteyInfluenza Centre, Department of Clinical Science, University of Bergen, Bergen, Norway.
Fan ZhouInfluenza Centre, Department of Clinical Science, University of Bergen, Bergen, Norway.
Rebecca J CoxInfluenza Centre, Department of Clinical Science, University of Bergen, Bergen, Norway.
Tom H M OttenhoffDepartment of Infectious Diseases, Leiden University Medical Center, Leiden, Netherlands.
Anne M Dyrhol-RiiseDepartment of Infectious Diseases, Oslo University Hospital, Oslo, Norway.
Unni C NygaardSection of Immunology, Department of Method Development and Analytics, Norwegian Institute of Public Health, Oslo, Norway.
Fredrik OftungSection of Immunology, Department of Method Development and Analytics, Norwegian Institute of Public Health, Oslo, Norway.
Siri MjaalandSection of Immunology, Department of Method Development and Analytics, Norwegian Institute of Public Health, Oslo, Norway.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Influenza viruses with pandemic potential and possible burden of post-viral sequelae are a global concern. To prepare for future pandemics and the development of improved vaccines, it is vital to identify the immunological changes underlying influenza disease severity. Methods: We combined unsupervised high-dimensional single-cell mass cytometry with gene expression analyses, plasma CXCL13 measurements, and antigen-specific immune cell assays to characterize the immune profiles of hospitalized patients with severe and moderate seasonal influenza disease during active infection and at 6-month follow-up. We used age-matched healthy donors as controls. Results: Severe disease was associated with a distinct immune profile, including lower frequencies of ICOS Conclusions: Our results indicated a reduction in regulatory MAIT cells and memory T and B cells and an increase in the inhibitory subpopulations of monocytes and NK cells in severe influenza that persisted at convalescence. These immune cell alterations were associated with higher age and the presence of several underlying conditions that may contribute to frailty. This study illustrates the power and sensitivity of high-dimensional single-cell analyses in identifying potential cellular biomarkers for disease severity after influenza infection.

Indexed as

Influenza, HumanSingle-Cell AnalysisAdultAgedChemokine CXCL13FemaleHumansImmunophenotypingMaleMiddle AgedSeasonsSeverity of Illness IndexYoung AdultChemokine CXCL13CXCL13 protein, humanbiomarkersdisease severityhospitalizationimmune profilinginfluenzamass cytometry

Identifiers

PMID40766325
PMCPMC12322504

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.